๐ก Get more than just numbers. Subscribe to access AI-powered analysis of company reports โ key trends and metrics in a simple, easy-to-understand format.
Estimate
P/E
55.1
EPS
1.68
Beta
0.855
Growth
Revenue, YoY
13.63%
Net income, YoY
-26.65%
Forecast
P/E (FWD)
27.4
EPS (FWD)
3.374
About the company
Ticker
EW
ISIN
US28176E1082
Country
United States of America
Sector (GICS)
Healthcare
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Frequently asked questions
What sector does Edwards Lifesciences Corporation (EW) operate in?
Edwards Lifesciences Corporation belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Edwards Lifesciences Corporation (EW) current stock price?
As of the latest data, Edwards Lifesciences Corporation stock price is $92.56, with a previous close of $93.05. Edwards Lifesciences Corporation lost -$0.49 in the last trading session, representing a -0.53% loss.
What is Edwards Lifesciences Corporation (EW) current market capitalization?
Edwards Lifesciences Corporation market cap is approximately 53.30 billion.
What is Edwards Lifesciences Corporation (EW) Earnings Per Share (EPS)?
The trailing EPS is $1.68, and the forward EPS is $3.37.
What is Edwards Lifesciences Corporation (EW) Price-to-Earnings (P/E) ratio?
Edwards Lifesciences Corporation current P/E ratio is 55.1, with a forward P/E of 27.44.
What is Edwards Lifesciences Corporation (EW) EBITDA?
Edwards Lifesciences Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 519.50 million.
Does Edwards Lifesciences Corporation (EW) pay dividends?
No. Edwards Lifesciences Corporation does not pay a dividend.
How did Edwards Lifesciences Corporation (EW) perform in its most recent earnings report?
In the last report (June 30, 2026), Edwards Lifesciences Corporation posted an EPS surprise of 6.85% and a revenue surprise of 2.44%.
What is Edwards Lifesciences Corporation (EW) beta (volatility) score?
Edwards Lifesciences Corporation has a beta of 0.855, meaning its volatility is roughly in line with the market.
